Diabetes care has not improved in the United States since 2005; persistent gaps and disparities in meeting care targets exist, particularly among young, female, and non-white adults with diabetes. JAMA Internal Medicine Rochelle Walensky, MD, MPH Deborah Wexler ja.ma/2OP6nsx

In a recent JAMA Internal Medicine a #MassGeneral team found #diabetes care hasn't improved in the US since 2005; persistent gaps and disparities in targets exist, particularly among young, female, and non-white adults. @KazemianPooyan Rochelle Walensky, MD, MPH Deborah Wexler wbur.org/commonhealth/2…

Always great to collaborate with @KazemianPooyan and Deborah Wexler on this important science highlighted by The New York Times today.

Thanks for an incredible case, showing the impact of compassionate, patient-centered care and #lifestylechange!

Vanita Aroda: the accidental role model… by no accident thelancet.com/journals/landi… #FREE to read with registration (also FREE) #ADA2021

Long-term comparative effectiveness trial shows GLP-1 agonist, insulin most effective for type 2 diabetes #GRADEStudy #ADA2021 Mass General MDs MassGeneral Medicine Harvard Medical School @MGHDiabetesEd NIDDK VIDEO:healio.com/news/endocrino…

GRADE: A head-to-head comparison of four metformin add-ons for type 2 diabetes diabetes.medicinematters.com/ada-2021/medic… #ADA2021 #GRADEStudy Mass General MDs MassGeneral Medicine Harvard Medical School @MGHDiabetesEd NIDDK

Many thanks to an incredible team for making this study possible! Miriam Udler Chirag Lakhani Jordi Merino Tim Majarian Alisa Manning Josep M Mercader 🎗

Sara Cromer's take on GRADE: A Comparative Effectiveness Trial for Type 2 Diabetes opmed.doximity.com/articles/grade… via Doximity

Excited to share this MGH Endocrine Fellowship collaboration exploring newly diagnosed diabetes at the time of hospitalization for COVID19: sciencedirect.com/science/articl… Have you read about “new-onset diabetes” from COVID19? Read on to learn what we found: Caitlin Colling Deborah Wexler

Racial/ethnic and socioeconomic disparities are ubiquitous. However, disparities shouldn't exist within a clinical trial providing participants with education, access to care, and even healthy food, right? Read on to see what we Deborah Wexler found in the Look AHEAD study!

In conclusion, a clinical trial should theoretically provide similar care to all participants, smoothing participant differences due to underlying health literacy, insurance and access to care, and provider implicit bias.

Our study shows that even extensive education and provision of needs like food did not overcome racial/ethnic disparities in care. Ongoing research on the impacts of interpersonal and structural racism and environmental justice may help elucidate reasons behind these disparities.

One of the many secondary analyses generating new evidence from the GRADE Study MGH Grade Study -- this one on kidney outcomes.

Thrilled to attend the MassGeneral Medicine Diabetes Unit research retreat and see a community of old friends and colleagues thriving under new Unit Chief Deborah Wexler. Feels like home! Diabetes research MassGeneral News has a bright future of innovation and discovery ahead.